Entropy Neurodynamics LimitedASX: ENP

Entropy Secures South African Psilocin Patent to 2043

· Issued by Entropy Neurodynamics Limited via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

Entropy Neurodynamics Limited has announced the grant of a South African patent for proprietary psilocin crystalline forms, enhancing its international intellectual property portfolio. The CEO emphasized that this expansion of the IP portfolio strengthens the company's competitive position and supports future clinical development and partnerships.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/entropy-secures-south-african-psilocin-patent-to-2043-1

Release

ASX Announcement ASX : ENP 9 November 2026 Global IP Portfolio Expanded with Grant of South African Patent to 2043 • South African patent granted for proprietary psilocin crystalline forms, further strengthening the Company’s international intellectual property (IP) portfolio • Follows the...

Entropy Neurodynamics Limited on 6ix

Earlier from Entropy Neurodynamics

Later from Entropy Neurodynamics

All Entropy Neurodynamics news releases